Winbp MT 20mg/25mg Tablet ER is a combination of two blood-pressure lowering medicines: Olmesartan and Metoprolol Succinate. Olmesartan is an angiotensin receptor blocker (ARB). It works by blocking the hormone angiotensin thereby relaxing blood vessels. Metoprolol Succinate is a beta blocker which works specifically on the heart to reduce heart rate and lower blood pressure. Together they allow the blood to flow more smoothly and the heart to pump more efficiently.
Taking Metoprolol with alcohol may have additive effects in lowering your blood pressure. You may experience headache, dizziness, lightheadedness, fainting, and/or changes in pulse or heart rate.
WEIGH RISKS VS BENEFITS
Winbp MT 20mg/25mg Tablet ER is unsafe to use during pregnancy. There is positive evidence of human fetal risk, but the benefits from use in pregnant women may be acceptable despite the risk, for example in life-threatening situations. Please consult your doctor.
Winbp MT 20mg/25mg Tablet ER is probably safe to use during lactation.
Limited human data suggests that the drug does not represent a significant risk to the baby.
Winbp MT 20mg/25mg Tablet ER may make you feel dizzy, sleepy, tired, or decrease alertness. If this happens, do not drive.
Winbp MT 20mg/25mg Tablet ER should be used with caution in patients with severe kidney disease. Dose adjustment of Winbp MT 20mg/25mg Tablet ER may be needed. Please consult your doctor. Regular monitoring of blood pressure is advisable for dose adjustment.
Winbp MT 20mg/25mg Tablet ER should be used with caution in patients with liver disease. Dose adjustment of Winbp MT 20mg/25mg Tablet ER may be needed. Please consult your doctor.